| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner
2 companies
Suvretta Capital Management, LLC is a Director, 10% Owner at Benitec Biopharma Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 49 buys and 0 sells.
Estimated insider holdings value: $152.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | MANE Veradermics, Inc | Director, 10% Owner | Buy | 282,674 | $37.30 | $10,542,477.61 | +1.1% | +180.3% | - | |
| Dec 29, 2025 | BNTC Benitec Biopharma Inc. | - | Buy | 144,223 | $13.20 | $1,903,132.88 | +0.4% | -25.4% | - | |
| Dec 22, 2025 | BNTC Benitec Biopharma Inc. | - | Buy | 46,141 | $11.68 | $538,972.28 | +0.1% | -9.4% | - | |
| Nov 7, 2025 | BNTC Benitec Biopharma Inc. | - | Buy | 1,481,481 | $13.50 | $19,999,993.50 | +15.0% | -8.9% | - | |
| Mar 31, 2025 | BNTC Benitec Biopharma Inc. | - | Buy | 16,497 | $12.83 | $211,736.04 | - | -10.1% | -18.1% | |
| Mar 26, 2025 | BNTC Benitec Biopharma Inc. | - | Buy | 900,000 | $13.00 | $11,700,000.00 | +10.0% | +6.9% | -22.8% | |
| Dec 24, 2024 | BNTC Benitec Biopharma Inc. | - | Buy | 47,520 | $11.09 | $527,174.46 | +0.3% | +23.8% | +12.7% | |
| Dec 3, 2024 | BNTC Benitec Biopharma Inc. | - | Buy | 42,000 | $9.60 | $403,200.00 | +0.5% | +24.2% | +25.8% | |
| Nov 20, 2024 | BNTC Benitec Biopharma Inc. | - | Buy | 41,436 | $10.05 | $416,615.92 | +0.2% | +5.6% | +23.3% |